Causal or casual? The role of causality assessment in pharmacovigilance

Drug Safety : an International Journal of Medical Toxicology and Drug Experience
R H MeyboomI R Edwards

Abstract

As with any other study method, 'spontaneous reporting' in pharmacovigilance is a process of data acquisition, assessment, presentation and interpretation. The provision of information (i.e. of interpreted data) concerning previously unknown, or otherwise important adverse drug reactions is a major goal. The assessment of case reports in spontaneous reporting takes place in 2 steps: first the assessment of each case individually, and secondly the interpretation of the aggregated data. The latter step is only completed for a minority of case reports, such as when actions or measures are deemed necessary. Uncertainty in case reports regarding the involvement of the suspected drugs is an inherent drawback of spontaneous reporting. Standardised case-causality assessment has become a routine at pharmacovigilance centres around the world. It aims at a decrease in ambiguity of the data and plays a role in data exchange and the prevention of erroneous conclusions. A variety of systems for standardised causality assessment have been developed, ranging from short questionnaires to comprehensive algorithms. Since none of the available assessment systems has been validated (i.e. shown to consistently and reproducibly produce a fair approxi...Continue Reading

Citations

May 3, 2012·Radiology·Jae-Woo JungSang-Heon Cho
Dec 10, 2013·Annals of Emergency Medicine·Stephen B FreedmanYaron Finkelstein
Jun 8, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Sinem Ezgi GulmezDominique Larrey
Feb 16, 2013·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Aboubacar A OumarPaul M Tulkens
Apr 14, 2005·European Journal of Clinical Pharmacology·Yannick ArimoneFrançoise Haramburu
Feb 18, 2011·European Journal of Clinical Pharmacology·Rosa M AntonijoanManel J Barbanoj
Jan 7, 2003·Pharmacoepidemiology and Drug Safety·Welmoed E E MeijerHubert G M Leufkens
Sep 29, 2001·Journal of Internal Medicine·I BuajordetT Hilberg
Mar 20, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Louisa E ChapmanRobert Shope
Mar 21, 2007·Expert Opinion on Drug Safety·Alan C Moss, Mark A Peppercorn
Jul 23, 2004·Expert Opinion on Drug Safety·Kees van Grootheest, Lolkje de Jong-van den Berg
Jan 7, 2014·Expert Opinion on Drug Safety·Saeedeh RaviSimin Dashti-Khavidaki
Dec 12, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·A J Scheen
Nov 18, 2015·Techniques in Coloproctology·P ChristensenA V Emmanuel
Apr 22, 2005·Journal of Veterinary Pharmacology and Therapeutics·K N Woodward
Aug 23, 2007·British Journal of Clinical Pharmacology·Yannick ArimoneBernard Bégaud
Mar 3, 2009·Journal of Clinical Pharmacy and Therapeutics·T J Steiner, M Voelker
Jul 2, 2011·Journal of Clinical Pharmacy and Therapeutics·M M MiljkovicV Dragojevic-Simic
Jan 31, 2015·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Jae-Woo JungHye-Ryun Kang
May 27, 2014·The Tohoku Journal of Experimental Medicine·Jae-Woo JungHye-Ryun Kang
Jul 14, 2016·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Hongkeun AhnKyoung Sup Hong
Dec 30, 2014·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·S CederholmG N Norén
Apr 10, 2004·Pharmacoepidemiology and Drug Safety·P C Waller, E H Lee
Feb 7, 2017·PloS One·Fabiana Rossi VaralloPatricia de Carvalho Mastroianni
Nov 4, 2016·The American Journal of Tropical Medicine and Hygiene·Krishna PandeyPradeep Das
Nov 24, 2016·Pharmacoepidemiology and Drug Safety·Alexandra C PacurariuSabine M Straus
Jan 25, 2017·European Archives of Psychiatry and Clinical Neuroscience·Mar Carceller-SindreuEnric Álvarez
Jan 24, 2017·Journal of Pharmacy Practice·Cory M HaleChristopher D Miller
Jul 12, 2018·Expert Opinion on Drug Safety·Jérémy LardonCédric Bousquet
Sep 1, 2018·Pharmacoepidemiology and Drug Safety·Ingrid OosterhuisEugène Paul van Puijenbroek
Sep 10, 2009·The Journal of Rheumatology·Lee S SimonPeter S Tugwell
Jun 1, 2007·Clinical Pharmacology and Therapeutics·J S AlmenoffN Yuen
Sep 8, 2007·Pharmacoepidemiology and Drug Safety·Mohammad Reza JavadiSeid Mahdi Mirsaeedi
Aug 30, 2008·British Journal of Clinical Pharmacology·Zakir Shaik MohammedKhan Rahat Ali
Apr 22, 2005·Pharmacoepidemiology and Drug Safety·K GholamiN Assasi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Annals of Pharmacotherapy
Eugène P van PuijenbroekHubert G M Leufkens
Drug Safety : an International Journal of Medical Toxicology and Drug Experience
R H MeyboomY A Hekster
Drug Safety : an International Journal of Medical Toxicology and Drug Experience
Maria Teresa HerdeiroAdolfo Figueiras
© 2021 Meta ULC. All rights reserved